2nd Quarter - Report — MAYO CLINIC for MAYO CLINIC (2021)

Firm

MAYO CLINIC

Client

MAYO CLINIC

Income

—

Expenses

$190,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Reimbursement and technology issues related to veterans health services

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Telemedicine and acute care at home; Laboratory Medicine payment and oversight, Medical research programs and funding; Quality; Regulatory relief; COVID/pandemic response

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; telemedicine and acute care at home

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Drug shortages; supply chain disruption

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

Support of clinical trials and research related to COVID-19; laboratory medicine; medical research funding

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Telemedicine technology; New diagnostic tests, Precision medicine; Broadband expansion and Internet access; Privacy and data security and usage

Lobbyist	Covered position, as disclosed
ANNE ROHALL-ANDRADE New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.